Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous ketorolac for prevention of post-hemorrhoidectomy pain
IRCT20240808062692N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of ketorolac and pethidine in hemorrhoid (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Postoperative pain score at 1 hour, Postoperative pain score at 4 hours and 5 more. Started Sep 2024; status: completed.
02
Drugs
ketorolacpethidine
03
Conditions
hemorrhoid
Beyond the preview
Go deeper on IRCT20240808062692N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240808062692N1.